SUSPENSION FOR FAECAL MICROBIOTA TRANSPLANTATION clinical trials

Effect of faecal microbiota transplant on the expression of autism spectrum disorder core symptoms in children – open-label phase II clinical trial (FMT-PAS)

This study is exploring if a special treatment called a faecal microbiota transplant (FMT) can help reduce some core symptoms of autism in children. It's a Phase II trial, meaning it's still an early stage of testing to see how well it works and if it's safe.